Clinical Trials Sponsored by Sana Pharmaceutical Industry
Total 173 results
-
Chulalongkorn UniversityBerlin Pharmaceutical IndustryTerminated
-
King Hussein Cancer CenterACDIMA Biocenter; Sana Pharmaceutical Industry; Amman Pharmaceutical Industries...Withdrawn2019 Novel CoronavirusJordan
-
Hospital do CoracaoMedley Pharmaceutical Industry SACompleted
-
Ministry of Health JordanKing Hussein Cancer Center; ACDIMA Biocenter; Amman Pharmaceutical Industries; Sana...Recruiting2019 Novel CoronavirusJordan
-
Genuine Research Center, EgyptInternational Drug Agency for Pharmaceutical IndustryCompleted
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
SamA Pharmaceutical Co., LtdCompletedPerennial Allergic RhinitisKorea, Republic of
-
SamA Pharmaceutical Co., LtdUnknown
-
SamA Pharmaceutical Co., LtdCompleted
-
Queen's University, BelfastMedicines Optimisation Innovation Centre (MOIC); Association of the British...CompletedMedication AdherenceUnited Kingdom
-
Dana-Farber Cancer InstituteRegeneron PharmaceuticalsActive, not recruitingAdvanced Cancer | Cutaneous Squamous Cell CarcinomaUnited States
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompleted
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompletedHypopharyngeal Cancer | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Early Invasive Cervical Squamous Cell Carcinoma | Cancer of Nasopharynx | Carcinoma of LarynxUnited States
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompletedTuberous Sclerosis Complex | TSC1 | TSC2 | MTORUnited States
-
Dana-Farber Cancer InstituteJanssen PharmaceuticaActive, not recruitingProstate CancerUnited States
-
Dana-Farber Cancer InstituteJanssen PharmaceuticalsTerminatedProstate CancerUnited States
-
Dana-Farber Cancer InstituteProgenics Pharmaceuticals, Inc.Not yet recruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Castration-resistant Prostate CarcinomaUnited States
-
Dana-Farber Cancer InstituteAVEO Pharmaceuticals, Inc.CompletedPancreatic CancerUnited States
-
Biohaven Pharmaceuticals, Inc.Dana-Farber Cancer InstituteRecruitingMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedThyroid Cancer | Differentiated Thyroid Cancer | Anaplastic Thyroid CancerUnited States
-
Dana-Farber Cancer InstituteAcetylon Pharmaceuticals IncorporatedActive, not recruitingRecurrent Chronic Lymphoid LeukemiaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.Completed
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedChronic Graft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteBiohaven Pharmaceuticals, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteSynta Pharmaceuticals Corp.TerminatedMelanomaUnited States
-
Dana-Farber Cancer InstituteAMAG Pharmaceuticals, Inc.WithdrawnEsophageal Cancer
-
Par Pharmaceutical, Inc.Cetero Research, San AntonioCompletedTo Determine Bioequivalence Under Fasting Conditions
-
Par Pharmaceutical, Inc.Cetero Research, San AntonioCompletedTo Determine Bioequivalence Under Fasting Conditions
-
Par Pharmaceutical, Inc.Cetero Research, San AntonioCompletedTo Determine the Bioequivalence Under Fasting ConditionsUnited States
-
University of California, San DiegoBioMarin PharmaceuticalWithdrawnBehavioral Manifestations of Lesch-Nyhan DiseaseUnited States
-
University of California, San FranciscoJazz PharmaceuticalsNot yet recruitingLocally Advanced Soft Tissue SarcomaUnited States
-
University of California, San FranciscoJazz PharmaceuticalsNot yet recruitingThrombotic Microangiopathies | Neuroblastoma | High-risk Neuroblastoma | Transplant-Associated Thrombotic MicroangiopathyUnited States
-
Neurotech PharmaceuticalsUniversity of California, San FranciscoCompletedRetinitis Pigmentosa | Usher Syndrome Type 2 | Usher Syndrome Type 3United States
-
University of California, San FranciscoFerring PharmaceuticalsCompletedKnee OsteoarthritisUnited States
-
University of California, San FranciscoNovartis PharmaceuticalsWithdrawn
-
University of California, San DiegoJazz PharmaceuticalsTerminatedAML | AML, Adult | Acute Myeloid Leukemia, AdultUnited States
-
University of California, San FranciscoFerring PharmaceuticalsCompleted
-
University of California, San DiegoAerie PharmaceuticalsWithdrawnOAG - Open-Angle Glaucoma | OHT - Ocular Hypertension
-
University of California, San FranciscoNovartis PharmaceuticalsCompleted
-
Rady Children's Hospital, San DiegoValeant PharmaceuticalsCompleted
-
Dana-Farber Cancer InstituteAstraZeneca; Cyclacel Pharmaceuticals, Inc.Active, not recruiting
-
Dana-Farber Cancer InstituteNovartis; Millennium Pharmaceuticals, Inc.TerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Oana DanciuNovartis PharmaceuticalsRecruitingHER2-negative Breast Cancer | Locoregional Recurrence | Hormone Receptor-positive Breast CancerUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
University of California, San FranciscoJanssen PharmaceuticalsActive, not recruitingCastration-Resistant Prostate Carcinoma | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of TestosteroneUnited States
-
University of California, San FranciscoRegeneron PharmaceuticalsCompletedAtopic Dermatitis | Atopic Dermatitis EczemaUnited States
-
University of California, San FranciscoJanssen PharmaceuticalsCompleted